Tenax Therapeutics, Inc. (TENX)

CIK 34956 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Tenax Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 2026SCHEDULE 13G/A0001140361-26-036327
Sep 9, 20268-K0001193125-26-385910
Sep 8, 2026SCHEDULE 13G0001104659-26-105941
Sep 8, 2026SCHEDULE 13G/A0000315066-26-002289
Sep 8, 202640001940272-26-000020
Sep 2, 202640001940272-26-000019
Aug 27, 2026SCHEDULE 13G0001178913-26-004262
Aug 27, 2026SCHEDULE 13G0001140361-26-034749
Aug 24, 202630001940272-26-000016
Aug 24, 202640001940272-26-000017
Aug 18, 2026SCHEDULE 13G0001104659-26-098450
Aug 14, 2026SCHEDULE 13G/A0001493215-26-000159
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000935
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352960
Aug 14, 2026SCHEDULE 13G/A0001193125-26-352650
Aug 14, 2026SCHEDULE 13G/A0001213900-26-090068
Aug 14, 2026SCHEDULE 13G/A0000921895-26-002186
Aug 12, 2026SCHEDULE 13G/A0000919574-26-004973
Aug 10, 20268-K0001193125-26-341236
Jul 31, 2026SCHEDULE 13D/A0001193125-26-328603
Jul 31, 20268-K0001193125-26-326784
Jul 31, 202610-Q0001193125-26-327455
Jul 30, 2026SCHEDULE 13G0002012383-26-003107
Jul 17, 2026SCHEDULE 13G/A0001104659-26-084723
Jul 14, 202640001193125-26-303600